ApoE ε4 allele is associated with incidental hallucinations and delusions in patients with AD
Citation Manager Formats
Make Comment
See Comments
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Abstract
Of 135 patients with Alzheimer disease (AD), 56 without psychiatric symptoms at the first visit were followed for a mean period of 51.9 ± 10.3 months to identify incident psychiatric symptoms. The hazard ratios of ApoE ε4 allele in developing psychiatric symptoms were calculated by Cox regression hazard analyses. The presence of the ApoE ε4 allele carried a 19.0-fold risk for developing hallucinations and a 3.4-fold risk for delusions.
- Received February 16, 2004.
- Accepted in final form May 14, 2004.
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. David Beversdorf and Dr. Ryan Townley
► Watch
Related Articles
- No related articles found.
Alert Me
Recommended articles
-
Articles
Serum cholesterol and risk of Alzheimer diseaseA community-based cohort studyG. Li, J. B. Shofer, W. A. Kukull et al.Neurology, October 10, 2005 -
Articles
The apolipoprotein E ϵ4 allele is not associated with psychiatric symptoms or extrapyramidal signs in probable Alzheimer's diseaseO. L. Lopez, M. I. Kamboh, J. T. Becker et al.Neurology, September 01, 1997 -
Articles
Head circumference and incident Alzheimer’s diseaseModification by apolipoprotein EA. Borenstein Graves, J. A. Mortimer, J. D. Bowen et al.Neurology, October 23, 2001 -
Articles
Effects of apolipoprotein E on dementia and aging in the Shanghai Survey of DementiaR. Katzman, M.-Y. Zhang, P. J. Chen et al.Neurology, September 01, 1997